Bio Techne Corp Stock Beta
| TE1 Stock | 71.50 0.50 0.69% |
Bio Techne Corp fundamentals help investors to digest information that contributes to Bio-Techne Corp's financial success or failures. It also enables traders to predict the movement of Bio-Techne Stock. The fundamental analysis module provides a way to measure Bio-Techne Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio-Techne Corp stock.
Bio-Techne |
Bio Techne Corp Company Beta Analysis
Bio-Techne Corp's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Bio Techne Corp has a Beta of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Beta (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Bio-Techne Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio-Techne Corp's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio-Techne Corp could also be used in its relative valuation, which is a method of valuing Bio-Techne Corp by comparing valuation metrics of similar companies.Bio Techne is currently under evaluation in beta category among its peers.
Bio-Techne Fundamentals
| Current Valuation | 13.06 B | |||
| Price To Book | 7.56 X | |||
| Price To Sales | 12.34 X | |||
| Revenue | 1.11 B | |||
| EBITDA | 413.76 M | |||
| Net Income | 272.05 M | |||
| Total Debt | 243.41 M | |||
| Cash Flow From Operations | 325.27 M | |||
| Price To Earnings To Growth | 1.11 X | |||
| Market Capitalization | 16.22 B | |||
| Total Asset | 2.29 B | |||
| Z Score | 39.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 2.29 B |
About Bio-Techne Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Techne Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio-Techne Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio-Techne Stock Analysis
When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.